Currently the Enterprise Value (EV) is not available for Amneal Pharmaceuticals.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 1.41,
with a Debt / Equity ratio of -23.73.
1.41
0.86
-23.73
5.9
10.66
0.96
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$336.62K
$-14.08K
8,300
0.8
2.9
Taxes
18.86M
-34.29%
Stock Price Statistics
The stock price has increased by 17.37% in the
last 52 weeks. The beta is 1.12, so Amneal Pharmaceuticals's
price volatility has been higher than the market average.
1.12
17.37%
7.99
8.07
64.3
1,616,912
Income Statement
In the last 12 months, Amneal Pharmaceuticals had revenue of 2.79B
and earned -116.89M
in profits. Earnings per share was -0.38.